Mezun Olduğu Tıp Fakültesi ve Yılı
İstanbul Üniversitesi Tıp Fakültesi, 1995
Uzmanlık Eğitimi Aldığı Yer ve Yılı
İstanbul Üniversitesi, 2001
Mesleki Deneyim
Medicana Çamlıca Hastanesi, 2026-Halen
Beykent Üniversitesi, 2025
Biruni Üniversitesi, 2023-2024
Aydın Üniversitesi, 2017-2018
Tıbbi İlgi Alanları
Diabetes Mellitus (Tip 1 ve Tip 2) – insülin yönetimi ve ileri tedavi protokolleri dahil
Obezite ve Metabolik Sendrom
Tiroid Bozuklukları
Lipid ve Lipid Metabolizması Bozuklukları
Hipofiz ve Adrenal Bozuklukları
Metabolik Kemik Hastalığı
Hormonal Yönetim ve Replasman Tedavileri
Özellikli İşlemler
Tiroid İnce İğne Aspirasyon Biyopsisi
Bilimsel Yayınlar
Uluslararası Hakemli Dergilerde Yayınlanan Makaleler
Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)
Exocrine Pancreatic Insufficiency in Diabetes: Association with Cardiovascular Disease and Insulin Therapy. Balamir M, Tanyolaç S, et al. J Clin Med. 2026;15(4):1023. doi: 10.3390/jcm15041023.
Insulin Resistance and Cancer: In Search for a Causal Link. Chiefari E, Tanyolaç S, et al. Int J Mol Sci. 2021 Oct 15;22(20):11137. doi: 10.3390/ijms222011137.
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes. Mirabelli M, Chiefari E, Caroleo P, Arcidiacono B, Corigliano DM, Giuliano S, Brunetti FS, Tanyolaç S, Foti DP, Puccio L, Brunetti A. Int J Environ Res Public Health. 2019 Dec 27;17(1):207. doi: 10.3390/ijerph17010207.
Evidence that an HMGA1 gene variant associates with type 2 diabetes, BMI, and HDL cholesterol in a Hispanic-American population. Pullinger CR, Goldfine ID, Tanyolac S, et.al. Metab Syndr Relat Disord. 2014;12(1):25-30. doi: 10.1089/met.2013.0086.
A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Chiefari E, Tanyolaç S, Iiritano S, et.al. Sci Rep. 2013;20(3):1491.
Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530. Brunetti A, Chiefari E, Pullinger CR, Tanyolac S, Foti D, Durlach V, Goldfine ID. Diabetes. 2012 May;61(5):e3. doi: 10.2337/db12-0051.
Bonnefond A, Lomberk G, Buttar N, Busiah K, Vaillant E, Lobbens S, Yengo L, Dechaume A, Mignot B, Simon A, Scharfmann R, Neve B, Tanyolaç S, Hodoglugil U, Pattou F, Cavé H, Iovanna J, Stein R, Polak M, Vaxillaire M, Froguel P, Urrutia R. "Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus." J Biol Chem. 2011 Aug 12;286(32):28414-24.
Brunetti A, Chiefari E, Pullinger CR, Tanyolac S, Foti D, Durlach V, Goldfine ID. "Low Frequency Variants in HMGA1 are associated with Type 2 Diabetes." Diabetes. 2012 May;61(5):e3.
Chiefari E, Tanyolaç S, Paonessa F, Pullinger CR, Capula C, Iiritano S, Mazza T, Forlin M, Fusco A, Durlach V, Durlach A, Malloy MJ, Kane JP, Heiner SW, Filocamo M, Foti DP, Goldfine ID, Brunetti A. "Functional variants of the HMGA1 gene and type 2 diabetes mellitus." JAMA. 2011 Mar;305(9):903-912.
Tanyolaç S, Bremer AA, Hodoglugil U, Movsesyan I, Pullinger CR, Heiner SW, Malloy MJ, Kane JP, Goldfine ID. "Genetic Variants of the ENPP1/PC-1 Gene Are Associated with Hypertriglyceridemia in Male Subjects." Metab Syndr Relat Disord. 2009 Dec;7(6):543-8.
Kurtoglu S, Atabek ME, Dizdarer C, Pirgon O, Isguven P, Emek S; PREDICTIVE Turkey Study Group. "Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE observational study." Pediatr Diabetes. 2009 Sep;10(6):401-7.
Tanyolaç S, Mahley RW, Hodoglugil U, Goldfine ID. "Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population." Obesity (Silver Spring). 2008 Nov;16(11):2468-71.
Tanyolaç S, Sertkaya Cikim A, Doğan Azezli A, Orhan Y. "Correlation between educational status and cardiovascular risk factors in an overweight and obese Turkish female population." Anadolu Kardiyol Derg. 2008 Oct;8(5):336-41.
Tanyolaç S, Cikim Sertkaya A, Azezli AD, Orhan Y. The alarm and action levels of waist circumference in overweight and obese Turkish women. Obesity Research & Clinical Practice. 2007 Dec;4(1):253-259.
Ozbey N, Sencer A, Tanyolac S, Kurt R, Sencer S, Bilgic B, Turantan I, Molvalilar S. "An intrasellar germinoma with normal cerebrospinal fluid beta-HCG concentrations misdiagnosed as hypophysitis." Hormones (Athens). 2006 Jan-Mar;5(1):66-70.
Hodoglugil U, Tanyolaç S, Williamson DW, Huang Y, Mahley RW. "Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks." J Lipid Res. 2006 Jan;47(1):144-53.
İdari Görevler
T.C. Sağlık Bakanlığı İstanbul Kanuni Sultan Süleyman Eğitim Araştırma Hastanesi İç Hastalıkları Eğitim Sorumlusu, 2015
Patentler
Brunetti A, Chiefari E.D., Foti D, Paonessa F, Iiritano S, Goldfine I.D., Kane J.P., Malloy M, Pullinger C, Tanyolac S. "POLIMORFISMO DEL GENE HMGA1, METODO DI INDIVIDUAZIONE E METODO DI DIAGNOSI GENETICA DI INSULINO-RESISTENZA E/O DIABETE MELLITO DI TIPO 2". Catanzaro, Italy, patent no: CZ2009A000009, 06/06/2009.
Brunetti A, Chiefari E.D., Foti D, Paonessa F, Iiritano S, Goldfine I.D., Kane J.P., Malloy M, Pullinger C, Tanyolac S. "GENETİC MUTATIONS PREDICTIVE OF TYPE 2 DIABETES". University of California San Francisco, California, USA, docket no: UCSF-412. Serial number: P-116454. License number: 542147
Ödüller
Functional variants of the HMGA1 gene cause a major decrease in Insulin receptor expression adlı çalışma ile 7th Annual World Congress on Insulin Resistance, November 2009, San Francisco, USA. En iyi araştırmacı ödülü.
Üye Olunan Dernekler
The Endocrine Society
American Association of Clinical Endocrinologists
American Diabetes Association
Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD)
Türk İç Hastalıkları Uzmanlık Derneği
Türkiye Obezite Derneği